Admin-Core-001

管理核心-001

基本信息

批准号：
10281419
负责人：
Flavio Francisco Marsiglia
金额：
$ 344.46万
依托单位：
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-09-22 至 2023-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10281419
关键词：
2019-nCoV Address African American American Indians Area Arizona Award COVID-19 COVID-19 pandemic Caring Collaborations Color Communities Community Health Aides Data Diagnostic Diagnostic tests Disease Economics Ecosystem Education Emergency Situation Ethical Issues Evaluation Family Fostering Foundations Funding Future Geographic Locations Goals Government Health Health Services Home environment Home visitation Hour Infrastructure Interdisciplinary Study Intervention Knowledge Laboratories Lead Mission Modeling Morbidity - disease rate Notification Participant Population Public Health Readiness Research Saliva Sampling Services Site Social Work Specialized Center Swab Test Result Testing Time Training Trust United States National Institutes of Health Vaccines barrier to care base care delivery care providers cohort community based participatory research community organizations community partnership comparison group disparity reduction experience follow-up health disparity health equity improved innovation member minority communities molecular diagnostics mortality racial and ethnic recruit research clinical testing response sample collection service providers social social health determinants uptake

项目摘要

Title: Eliminating COVID-19 disparities in Arizona in partnership with underserved/vulnerable communities Abstract Arizona has one of the highest COVID-19 positivity test rates (approximately 19%) in the U.S. Positivity rates are disproportionally higher among Arizona's Latinx, American Indian and African American communities. The proposed community driven and culturally congruent intervention aims to increase access to testing by identifying and decreasing barriers to testing in vulnerable and underserved communities across Arizona. The intervention aims at reducing disparities in COVID-19 diagnostics, education, wraparound services and referrals to a primary care provider, with the ultimate goal of improving the health of underserved communities. The proposed approach empowers local communities, meets community members where they are, is data driven, and creates the infrastructure for continued community-driven delivery of care. Following a Community Based Participatory Research (CBPR) orientation, the project will: (a) identify and prioritize testing deserts, (b) coordinate testing at different levels of the social ecosystem, (c) engage and train local Community Health Workers (CHWs) deliver saliva-based COVID-19 testing to vulnerable and underserved community members, (d) deliver test results within 72 hours, (e) provide wrap-around services and provider referrals for those testing positive, and (f) sustain the intervention during a follow-up period. Equality Health Foundation serves as the lead community partner and convener of a growing COVID- 19 Coalition of Communities of Color Partners (CCCCP) from across Arizona. The ASU Biodesign Clinical Testing Laboratory (ABCTL) will provide the saliva-based SARS-CoV-2 molecular diagnostic. The saliva test's main benefits are: a) minimal to no PPE requirements compared to nasopharyngeal (NP) swabs; b) convenience and economy of specimen collection; c) ease of repeat sampling; d) administration by minimally trained CHWs and e) greater sensitivity and consistency of saliva tests than NP swabs. The project aims to administer 29,000 saliva tests, 10,000-12,000 at identified testing deserts during the launching period, doubling the numbers during the follow-up period in Year 1, and adding 5,000 tests in Year 2. A longitudinal evaluation will assess the intervention's impact by comparing randomly selected participants in the R.A.P.I.D. intervention during the launching period (N=500) with a matched comparison group (N=500) randomly selected from standard testing sites. ASU's existing NIMHD-funded U54 Specialized Center of Excellence (RFA-MD-17-005; 5U54MD002316-14) with its Community Advisory Board and in collaboration with key government, community organizations, tribal governments and academic partners is well equipped and eligible to undertake the proposed revision. The aims of this emergency competitive revision match and enhance the aims of the current U54 award and the assembled transdisciplinary team has the infrastructure, capacity, and community partnerships in place to implement the project.

标题：与服务不足/脆弱的人合作，消除亚利桑那州的共同差异社区抽象的亚利桑那州是美国阳性率最高的Covid-19阳性测试率（约19％）之一亚利桑那州，美国印第安人和非裔美国人社区的比率不成比例地更高。拟议的社区驱动和文化上一致的干预旨在通过在亚利桑那州的脆弱和服务不足的社区中识别和减少测试障碍。这干预旨在减少COVID-19诊断，教育，环绕式服务和转介给初级保健提供者，其最终目标是改善服务不足社区的健康。拟议的方法赋予当地社区，与他们所处的社区成员会面，是数据被驱动，并创建基础设施，以继续以社区为导向的护理。遵循社区的参与性研究（CBPR）取向，该项目将：（a）确定并优先考虑测试沙漠，（b）协调社会生态系统不同级别的测试，（c）参与和培训当地社区卫生工作者（CHWS）将基于唾液的Covid-19测试提供给脆弱的和服务不足的社区成员，（d）在72小时内提供测试结果，（e）提供包裹的服务以及提供者转介对那些阳性测试的人进行推荐，（f）在随访期内维持干预措施。平等健康基金会是越来越多的共同伙伴和召集人的召集人 19来自亚利桑那州各地的色彩合作伙伴社区联盟（CCCCP）。 ASU生物设计临床测试实验室（ABCTL）将提供基于唾液的SARS-COV-2分子诊断。唾液测试主要好处是：a）与鼻咽（NP）拭子相比，没有PPE的最小要求； b）标本收集的便利和经济； c）易于重复抽样； d）最少给予受过训练的CHW和E）唾液测试的敏感性和一致性比NP拭子更高。该项目旨在在发射期间，在确定的测试沙漠中管理29,000次唾液测试，10,000-12,000 在第1年的随访期间的数字，并在第2年增加了5,000次测试。纵向评估将通过比较R.A.P.I.D.中随机选择的参与者来评估干预措施的影响。干涉在启动期（n = 500）中，随机选择了一个匹配的比较组（n = 500）标准测试站点。 ASU现有的NIMHD资助的U54专业卓越中心（RFA-MD-17-005； 5U54MD002316-14）及其社区咨询委员会，并与主要政府合作组织，部落政府和学术合作伙伴有足够的能力，有资格进行拟议的修订。这种紧急竞争性修订匹配的目的并增强了当前的目标 U54奖和集会的跨学科团队拥有基础设施，能力和社区实施该项目的合作伙伴关系。